Skip to main content

RemSleep Holdings Inc.

corporate_fare Company Profile

RemSleep Holdings Inc.

RMSL·OTC·Trade & Services·CIK 0001412126

REMSleep Holdings, Inc. develops and distributes products globally to assist individuals affected by sleep apnea. The company provides the DeltaWave CPAP interface device, which is used to treat patients with sleep apnea. It serves durable medical equipment providers, hospital and acute care facilities, sleep labs, physicians, sleep and neurology specialists, and medical associations. The company's headquarters are located in Blackshear, Georgia.

RemSleep Holdings Inc. (OTC:RMSL) is a publicly traded company in the Trade & Services sector. Wiseek monitors RMSL SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • RemSleep Holdings Reports Tripled Q1 Net Loss, Critical Cash Burn, and Negative Equity Amidst Management Overhaul
  • RemSleep Holdings Undergoes Control Change, New Leadership, and Strategic Pivot
  • Annual Report Reveals Going Concern, Leadership Change, and Extreme Dilution Exceeding Authorized Shares
  • Founder/CEO Passes Away; New CEO Appointed with Highly Conditional Employment Terms

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
16.72K
Net Income
-3.02M
Diluted EPS
0.00
Op. Cash Flow
-502.83K
Gross Profit
4.01K
Operating Income
-2.77M
Cash & Equivalents
214.51K
Debt / Equity
0.00×
Net Margin
-180.63×
Shares Outstanding
1.66B sh
Source: 10-K · filed 2026-04-15 · accession 0001213900-26-044165

Dilution Risk

Low risk

Filing-implied dilution signals for RMSL, detected from its recent SEC filings · based on capital-structure filings through 2026-04-15.

Going Concern Warning Issued · Severe Financial Deterioration

⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

$0.0022
52-week range · as of 2026-06-09 $0.0012 – $0.012
Market cap
$3.73M
Volume
125K (0.1× avg)
3-mo avg 1.2M
Live data · 2026-07-27 21:58 UTC · After hours

show_chartPrice Chart

Loading chart...

feed RMSL - Latest Insights

RMSL
Jun 09, 2026, 7:34 PM EDT
Filing Type: 10-Q
Importance Score:
9
RemSleep Holdings Reports Tripled Q1 Net Loss, Critical Cash Burn, and Negative Equity Amidst Management Overhaul
Price at Filing: $0.00313
Real-time Price: $0.0022 info
Change: -$0.00093 (-30%) info
Market Cap: $3.728M info
Sentiment: Negative
View Wiseek Article
RMSL
Jun 04, 2026, 9:23 AM EDT
Filing Type: 8-K
Importance Score:
9
RemSleep Holdings Undergoes Control Change, New Leadership, and Strategic Pivot
Price at Filing: $0.0026
Real-time Price: $0.0022 info
Change: -$0.0004 (-15%) info
Market Cap: $3.728M info
Sentiment: Neutral
View Wiseek Article
RMSL
Apr 15, 2026, 5:26 PM EDT
Filing Type: 10-K
Importance Score:
9
Annual Report Reveals Going Concern, Leadership Change, and Extreme Dilution Exceeding Authorized Shares
Price at Filing: $0.0067
Real-time Price: $0.0022 info
Change: -$0.0045 (-67%) info
Market Cap: $3.728M info
Sentiment: Negative
View Wiseek Article
RMSL
Mar 04, 2026, 3:38 PM EST
Filing Type: 8-K
Importance Score:
9
Founder/CEO Passes Away; New CEO Appointed with Highly Conditional Employment Terms
Price at Filing: $0.0061
Real-time Price: $0.0022 info
Change: -$0.0039 (-64%) info
Market Cap: $3.728M info
Sentiment: Negative
View Wiseek Article